BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1036981)

  • 1. A comparison of drostanolone propionate (Masteril) and nandrolone decanoate (Deca-durabolin) in the treatment of breast carcinoma.
    Chowdhury MS; Banks AJ; Bond WH; Jones WG; Ward HW
    Clin Oncol; 1976 Sep; 2(3):203-6. PubMed ID: 1036981
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal therapy of breast cancer with special reference to Masteril therapy.
    Bennett MB; Helman P; Palmer P
    S Afr Med J; 1975 Nov; 49(49):2036-40. PubMed ID: 1242823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy of breast cancer with special reference to masteril therapy.
    Helman P; Bennett MB
    S Afr Med J; 1972 Aug; 46(34):1195-9. PubMed ID: 5068714
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of metastasising mammary carcinoma with drostanolone propionate (masterid) (author's transl)].
    von Lieven H; Büll U
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2043-6. PubMed ID: 4216810
    [No Abstract]   [Full Text] [Related]  

  • 5. [Androgen therapy of incurable breast neoplasms. Controlled clinical study: nandrolone-testololactone-drostanolone].
    Wolff G; Rieche K
    Onkologie; 1978 Aug; 1(4):172-4. PubMed ID: 362297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drostanolone propionate (masteril) in disseminated breast cancer in women. Immediate results].
    Marinov L; Tsekova V; Koĭnov K; Velikova M; Micheva D
    Khirurgiia (Sofiia); 1987; 40(6):80-6. PubMed ID: 2830431
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of testosterone decanoate, drostanolone and testololactone in disseminated breast cancer--a randomized clinical study.
    Rieche K; Wolff G
    Arch Geschwulstforsch; 1975; 45(5):485-8. PubMed ID: 1243528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of disseminated mammary carcinoma with drostanolone propionate.
    Brown IG
    Practitioner; 1970 Sep; 205(227):336-7. PubMed ID: 5536680
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term survival after treatment of breast cancer thoracic metastases through the association, right from the beginning, of hormonotherapy and non hormonal antineoplastic chemotherapy (author's transl)].
    Mannes P; Derriks R; Moens R
    Acta Tuberc Pneumol Belg; 1971; 62(5):473-77. PubMed ID: 5172849
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of mastisol (2-alpha-methylandrostan-17-beta-ol-3-one propionate) and testosterone propionate in the treatment of advanced and recurrent cancer of the breast.
    Amaaki T; Enomoto K; Shimada S; Nagai K; Minagawa N
    Nihon Geka Hokan; 1969 Jul; 38(4):652-7. PubMed ID: 5394603
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of disseminated mammary carcinoma with drostanolone propionate (Masterid). Report on 22 treated cases].
    Poddig-von Riegen S; Notter G
    Munch Med Wochenschr; 1971 Apr; 113(18):695-7. PubMed ID: 5108667
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
    Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
    Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-response evaluation of androgens in the treatment of metastatic breast cancer.
    Talley RW; Haines CR; Waters MN; Goldenberg IS; Olson KB; Bisel HF
    Cancer; 1973 Aug; 32(2):315-20. PubMed ID: 4579091
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced breast carcinoma with drostanolone propionate. A case report.
    Heney NM
    Bristol Med Chir J; 1970 Jul; 85(315):75-6. PubMed ID: 5536155
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormonal therapy of advanced breast cancer with drostanolone propionate].
    Petit JC; Klein T; Rodier D
    Bull Cancer; 1971; 58(4):511-22. PubMed ID: 4115657
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormones in advanced cancer.
    Br Med J; 1971 Jun; 2(5764):760-3. PubMed ID: 4253671
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and biochemical effects of nandrolone phenilpropionate (durabolin) and nandrolone decanoate (deca-durabolin) in diabetic retinopathies].
    HOUTSMULLER AJ; HENKES HE
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1961; 63():57-62. PubMed ID: 14449333
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination.
    Cole MP; Todd ID; Wilkinson PM
    Br J Cancer; 1973 May; 27(5):396-9. PubMed ID: 4576562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anabolic steroid boosts weight.
    GMHC Treat Issues; 1996 Sep; 10(9):8-9. PubMed ID: 11363845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deca-Durabolin and parenteral nutrition in post-traumatic patients.
    Mosebach KO; Hausmann D; Caspari R; Stoeckel H
    Acta Endocrinol Suppl (Copenh); 1985; 271():60-9. PubMed ID: 3934896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.